tisotumab vedotin fda approval

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
tisotumab vedotin fda approval	1.07	0.2	6247	76	30
tisotumab	1.67	0.7	726	25	9
vedotin	1.46	0.5	546	65	7
fda	0.5	0.9	3950	66	3
approval	0.45	0.3	447	74	8

Keyword	CPC	PCC	Volume	Score
tisotumab vedotin fda approval	1.22	0.9	9933	81
tisotumab vedotin ema approval	0.71	0.9	8198	95
tisotumab vedotin clinical trials	0.65	1	4325	7
enfortumab vedotin fda approval	0.82	0.6	1265	79
enfortumab vedotin fda approval history	0.11	0.9	8402	63
polatuzumab vedotin fda approval	1.58	0.6	6256	28
telisotuzumab vedotin fda approval	0.94	0.1	554	61
polatuzumab vedotin fda approval history	0.72	0.2	2878	86
disitamab vedotin fda approval	0.89	0.7	5566	64
tisotumab vedotin package insert	1.26	1	1885	77
tisotumab vedotin-tftv tivdak	0.41	0.4	9436	61
brentuximab vedotin fda approval	0.99	0.4	8744	84
tisotumab vedotin-tftv	1.87	0.9	4283	1
tisotumab vedotin j code	1.33	0.6	8858	47
tisotumab vedotin cervix zulassung	1.27	0.4	6835	10
tisotumab vedotin cervical cancer	0.11	0.8	2630	71
tisotumab vedotin empfehlung deutschland	0.27	0.1	9243	9
target antigen for tisotumab vedotin	1.41	0.8	2437	74
tisotumab vedotin cervix zulassung ema	0.86	0.3	2076	67
tisotumab vedotin mechanism of action	0.9	0.4	8089	75
tisotumab vedotin cancer ovaires	0.17	0.3	4666	19
enfortumab vedotin pembrolizumab fda	0.62	0.6	4709	56